Style | Citing Format |
---|---|
MLA | Godman B, et al.. "Fixed Dose Drug Combinations–Are They Pharmacoeconomically Sound? Findings and Implications Especially for Lower- and Middle-Income Countries." Expert Review of Pharmacoeconomics and Outcomes Research, vol. 20, no. 1, 2020, pp. 1-26. |
APA | Godman B, Mccabe H, Leong TD, Mueller D, Martin AP, Hoxha I, Mwita JC, Rwegerera GM, Massele A, De Oliveira Costa J, Do Nascimento RCRM, De Lemos LLP, Tachkov K, Milushewa P, Patrick O, Niba LL, Laius O, Sefah I, Abdulsalim S, ... Meyer JC (2020). Fixed Dose Drug Combinations–Are They Pharmacoeconomically Sound? Findings and Implications Especially for Lower- and Middle-Income Countries. Expert Review of Pharmacoeconomics and Outcomes Research, 20(1), 1-26. |
Chicago | Godman B, Mccabe H, Leong TD, Mueller D, Martin AP, Hoxha I, Mwita JC, et al.. "Fixed Dose Drug Combinations–Are They Pharmacoeconomically Sound? Findings and Implications Especially for Lower- and Middle-Income Countries." Expert Review of Pharmacoeconomics and Outcomes Research 20, no. 1 (2020): 1-26. |
Harvard | Godman B et al. (2020) 'Fixed Dose Drug Combinations–Are They Pharmacoeconomically Sound? Findings and Implications Especially for Lower- and Middle-Income Countries', Expert Review of Pharmacoeconomics and Outcomes Research, 20(1), pp. 1-26. |
Vancouver | Godman B, Mccabe H, Leong TD, Mueller D, Martin AP, Hoxha I, et al.. Fixed Dose Drug Combinations–Are They Pharmacoeconomically Sound? Findings and Implications Especially for Lower- and Middle-Income Countries. Expert Review of Pharmacoeconomics and Outcomes Research. 2020;20(1):1-26. |
BibTex | @article{ author = {Godman B and Mccabe H and Leong TD and Mueller D and Martin AP and Hoxha I and Mwita JC and Rwegerera GM and Massele A and De Oliveira Costa J and Do Nascimento RCRM and De Lemos LLP and Tachkov K and Milushewa P and Patrick O and Niba LL and Laius O and Sefah I and Abdulsalim S and Soleymani F and Guantai AN and Achieng L and Oluka M and Jakupi A and Logviss K and Azmi Hassali M and Kibuule D and Kalemeera F and Mubita M and Fadare J and Ogunleye OO and Saleem Z and Hussain S and Bochenek T and Mardare I and Alrasheedy AA and Furst J and Tomek D and Markovicpekovic V and Rampamba EM and Alfadl A and Amu AA and Matsebula Z and Thi Phuong TN and Thanh BN and Kalungia AC and Zaranyika T and Masuka N and Olaru ID and Wale J and Hill R and Kurdi A and Timoney A and Campbell S and Meyer JC}, title = {Fixed Dose Drug Combinations–Are They Pharmacoeconomically Sound? Findings and Implications Especially for Lower- and Middle-Income Countries}, journal = {Expert Review of Pharmacoeconomics and Outcomes Research}, volume = {20}, number = {1}, pages = {1-26}, year = {2020} } |
RIS | TY - JOUR AU - Godman B AU - Mccabe H AU - Leong TD AU - Mueller D AU - Martin AP AU - Hoxha I AU - Mwita JC AU - Rwegerera GM AU - Massele A AU - De Oliveira Costa J AU - Do Nascimento RCRM AU - De Lemos LLP AU - Tachkov K AU - Milushewa P AU - Patrick O AU - Niba LL AU - Laius O AU - Sefah I AU - Abdulsalim S AU - Soleymani F AU - Guantai AN AU - Achieng L AU - Oluka M AU - Jakupi A AU - Logviss K AU - Azmi Hassali M AU - Kibuule D AU - Kalemeera F AU - Mubita M AU - Fadare J AU - Ogunleye OO AU - Saleem Z AU - Hussain S AU - Bochenek T AU - Mardare I AU - Alrasheedy AA AU - Furst J AU - Tomek D AU - Markovicpekovic V AU - Rampamba EM AU - Alfadl A AU - Amu AA AU - Matsebula Z AU - Thi Phuong TN AU - Thanh BN AU - Kalungia AC AU - Zaranyika T AU - Masuka N AU - Olaru ID AU - Wale J AU - Hill R AU - Kurdi A AU - Timoney A AU - Campbell S AU - Meyer JC TI - Fixed Dose Drug Combinations–Are They Pharmacoeconomically Sound? Findings and Implications Especially for Lower- and Middle-Income Countries JO - Expert Review of Pharmacoeconomics and Outcomes Research VL - 20 IS - 1 SP - 1 EP - 26 PY - 2020 ER - |